Legal & General Group
PLRX icon

Legal & General Group’s Pliant Therapeutics PLRX Stock Holding History

Legal & General Group’s Portfolio PLRX Stock Details PLRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-52,961
Closed -$71.7K – 3506
2025
Q1 		$71.7K Hold
52,961
– – ﹤0.01% 2691
2024
Q4 		$697K Buy
52,961
+12,249
+30% +$167K ﹤0.01% 2347
2024
Q3 		$456K Buy
40,712
+333
+0.8% +$4.17K ﹤0.01% 2496
2024
Q2 		$434K Sell
40,379
-1,246
-3% -$16.1K ﹤0.01% 2465
2024
Q1 		$620K Sell
41,625
-109
-0.3% -$1.8K ﹤0.01% 2347
2023
Q4 		$756K Sell
41,734
-184
-0.4% -$2.8K ﹤0.01% 2304
2023
Q3 		$727K Sell
41,918
-418
-1% -$7.25K ﹤0.01% 2299
2023
Q2 		$767K Buy
42,336
+25,229
+147% +$597K ﹤0.01% 2312
2023
Q1 		$455K Buy
17,107
+7,381
+76% +$210K ﹤0.01% 2339
2022
Q4 		$188K Buy
+9,726
New +$203K ﹤0.01% 2633
2022
Q2 		– Sell
-5,792
Closed -$41K – 3622
2022
Q1 		$41K Hold
5,792
– – ﹤0.01% 3034
2021
Q4 		$78K Buy
5,792
+36
+0.6% +$572 ﹤0.01% 2957
2021
Q3 		$97K Buy
5,756
+2,454
+74% +$52.1K ﹤0.01% 2855
2021
Q2 		$96K Sell
3,302
-17
-0.5% -$529 ﹤0.01% 2752
2021
Q1 		$131K Buy
3,319
+2,177
+191% +$70.7K ﹤0.01% 2545
2020
Q4 		$26K Hold
1,142
– – ﹤0.01% 2991
2020
Q3 		$26K Sell
1,142
-3,858
-77% -$96.4K ﹤0.01% 2898
2020
Q2 		$161K Buy
+5,000
New +$133K ﹤0.01% 2406

Other funds holding PLRX

TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BOCH
Blue Owl Capital Holdings New York $372M AUM 78.25% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
MAP
Madison Avenue Partners New York $2.3B AUM 115.82% 1-Year Est. Return
TGI
TRV GP IV Boston, Massachusetts $267M AUM 965.83% 1-Year Est. Return

Legal & General Group's PLRX Position: Q2 2025 in Review

Legal & General Group sold out of Pliant Therapeutics (PLRX) in Q2 2025, closing a stake of 52,961 shares — an estimated $71.7K sold.

Legal & General Group first reported a position in PLRX in Q2 2020 and held it in 18 quarters. The position peaked at $767K in Q2 2023. 114 funds tracked by Wall St. Rank hold PLRX as of Q2 2025.

  • Legal & General Group reported no remaining Pliant Therapeutics position as of Q2 2025 after selling out during the quarter.
  • Legal & General Group sold 52,961 Pliant Therapeutics shares in Q2 2025, an estimated $71.7K.
  • Legal & General Group first reported a position in Pliant Therapeutics in Q2 2020 and held it in 18 quarters.
  • Legal & General Group's Pliant Therapeutics position peaked at $767K in Q2 2023.
  • 114 funds tracked by Wall St. Rank held Pliant Therapeutics as of Q2 2025.

Based on Legal & General Group's 13F filing for Q2 2025, filed 12 Aug 2025.